Astria Therapeutics Ownership | Who Owns Astria Therapeutics?

Astria Therapeutics Ownership Summary

Astria Therapeutics is owned by 100.05% institutional investors, 0.47% insiders. Perceptive advisors is the largest institutional shareholder, holding 12.40% of ATXS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.77% of its assets in Astria Therapeutics shares.

ATXS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Astria Therapeutics	100.05%	0.47%	-0.52%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Perceptive advisors	6.49M	12.40%	$59.02M
Fmr	6.05M	11.58%	$55.10M
Ra capital management	5.04M	9.64%	$45.90M
Vr adviser	3.61M	6.90%	$32.84M
Fairmount funds management	3.55M	6.80%	$32.34M
Blackrock	3.52M	6.73%	$32.01M
Vestal point capital, lp	3.25M	6.21%	$29.57M
Tcg crossover management	2.76M	5.28%	$25.13M
Vanguard group	2.59M	4.95%	$23.57M
Vivo capital	2.33M	4.45%	$21.19M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Fairmount funds management	3.55M	3.65%	$32.34M
Tcg crossover management	2.76M	2.62%	$25.13M
Vestal point capital, lp	3.25M	2.21%	$29.57M
Vr adviser	3.61M	2.09%	$32.84M
Vivo capital	2.33M	1.96%	$21.19M
Perceptive advisors	6.49M	1.40%	$59.02M
Sio capital management	510.27K	1.26%	$4.64M
Affinity asset advisors	975.61K	1.02%	$8.88M
Ra capital management	5.04M	0.61%	$45.90M
Dafna capital management	274.17K	0.60%	$2.49M

Top Buyers

Holder	Shares	% Assets	Change
Vestal point capital, lp	3.25M	2.21%	2.15M
Fmr	6.05M	0.00%	1.74M
Nantahala capital management	675.00K	0.36%	675.00K
Ra capital management	5.04M	0.61%	630.61K
Cubist systematic strategies	281.41K	0.02%	281.41K

Top Sellers

Holder	Shares	% Assets	Change
Tcg crossover management	2.76M	2.62%	-2.52M
Cormorant asset management, lp	-	-	-1.30M
Logos global management lp	-	-	-1.00M
Avidity partners management lp	-	-	-982.00K
Caption management	-	-	-976.30K

New Positions

Holder	Shares	% Assets	Change	Value
Nantahala capital management	675.00K	0.36%	675.00K	$6.14M
Cubist systematic strategies	281.41K	0.02%	281.41K	$2.56M
Qube research	119.67K	0.00%	119.67K	$1.09M
Tang capital management	100.00K	0.09%	100.00K	$910.00K
Clarivest asset management	80.31K	0.07%	80.31K	$730.87K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-7.00
Federated hermes	-84.00
Russell investments group	-396.00
Pacer advisors	-613.00
Point72 (difc)	-857.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	107	3.88%	56,513,751	1.68%	100	0.89%	48	-22.58%	38	46.15%
Jun 30, 2024	103	-17.60%	55,578,904	-3.56%	106	0.88%	62	-21.52%	26	13.04%
Mar 31, 2024	125	52.44%	57,630,802	56.36%	110	0.74%	79	43.64%	23	43.75%
Dec 31, 2023	82	17.14%	36,857,473	60.38%	122	1.82%	55	77.42%	16	-11.11%
Sep 30, 2023	70	-12.50%	22,981,516	-6.83%	81	1.06%	31	-32.61%	18	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.56M	2.77%	2.39K
Fidelity Small Cap Growth	1.35M	2.40%	-3.54K
FIAM Small Cap Core CIT Cl B	1.25M	2.22%	94.70K
iShares Russell 2000 ETF	1.16M	2.05%	-2.60K
Fidelity Advisor Biotechnology I	978.74K	1.73%	-
Fidelity Series Small Cap Opps	824.80K	1.46%	-
FIAM Small Cap Core Composite	734.29K	1.30%	734.29K
Heptagon Driehaus US Micro Cap Eq C$ Acc	613.25K	1.09%	4.99K
Fidelity Select Biotechnology	596.26K	1.06%	-
SPDR® S&P Biotech ETF	588.73K	1.04%	6.50K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 01, 2024	Morabito Christopher	Chief Medical Officer	Sell	$135.94K
Feb 01, 2024	PERCEPTIVE ADVISORS LLC	-	Buy	$30.00M
Jan 29, 2024	Morabito Christopher	Chief Medical Officer	Sell	$102.55K
Jan 26, 2024	Morabito Christopher	Chief Medical Officer	Sell	$8.81K
Dec 21, 2023	PERCEPTIVE ADVISORS LLC	-	Buy	$4.59M

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	-	1
2024 Q1	1	2
2023 Q4	7	-
2023 Q2	-	-
2022 Q4	1	-

ATXS Ownership FAQ

Who Owns Astria Therapeutics?

Astria Therapeutics shareholders are primarily institutional investors at 100.05%, followed by 0.47% insiders and -0.52% retail investors. The average institutional ownership in Astria Therapeutics's industry, Biotech Stocks , is 47.04%, which Astria Therapeutics exceeds.

Who owns the most shares of Astria Therapeutics?

Astria Therapeutics’s largest shareholders are Perceptive advisors (6.49M shares, 12.40%), Fmr (6.05M shares, 11.58%), and Ra capital management (5.04M shares, 9.64%). Together, they hold 33.62% of Astria Therapeutics’s total shares outstanding.

Does Blackrock own Astria Therapeutics?

Yes, BlackRock owns 6.73% of Astria Therapeutics, totaling 3.52M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.01M$. In the last quarter, BlackRock decreased its holdings by -67.913K shares, a -1.89% change.

Who is Astria Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Astria Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.65% of its assets in 3.55M Astria Therapeutics shares, valued at 32.34M$.

Who is the top mutual fund holder of Astria Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Astria Therapeutics shares, with 2.77% of its total shares outstanding invested in 1.56M Astria Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools